Litcius/Paper detail

SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR

Alice C. Eastman, Rhonda G. Pace, Hong Dang, Melis A. Aksit, Briana Vecchio-Pagán, Anh-Thu N. Lam, Wanda K. O’Neal, Scott M. Blackman, Michael R. Knowles, Garry R. Cutting

2021Journal of Cystic Fibrosis15 citationsDOIOpen Access PDF

Topics & Concepts

IvacaftorCystic fibrosisMedicineCystic fibrosis transmembrane conductance regulatorInternal medicineLung functionLungOncologyCystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchAsthma and respiratory diseases
SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR | Litcius